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Abstract
Mice deficient for the G protein subunit Gai2 spontaneously develop colitis, a chronic inflammatory disease associated with
dysregulated T cell responses. We and others have previously demonstrated a thymic involution in these mice and an
aberrant thymocyte dynamics. The Gai2
2/2 mice have a dramatically reduced fraction of double positive thymocytes and an
increased fraction of single positive (SP) thymocytes. In this study, we quantify a number of critical parameters in order to
narrow down the underlying mechanisms that cause the dynamical changes of the thymocyte development in the Gai2
2/2
mice. Our data suggest that the increased fraction of SP thymocytes results only from a decreased number of DP
thymocytes, since the number of SP thymocytes in the Gai2
2/2 mice is comparable to the control littermates. By measuring
the frequency of T cell receptor excision circles (TRECs) in the thymocytes, we demonstrate that the number of cell divisions
the Gai2
2/2 SP thymocytes undergo is comparable to SP thymocytes from control littermates. In addition, our data show
that the mature SP CD4
+ and CD8
+ thymocytes divide to the same extent before they egress from the thymus. By estimating
the number of peripheral TREC
+ T lymphocytes and their death rate, we could calculate the daily egression of thymocytes.
Gai2
2/2 mice with no/mild and moderate colitis were found to have a slower export rate in comparison to the control
littermates. The quantitative measurements in this study suggest a number of dynamical changes in the thymocyte
development during the progression of colitis.
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Introduction
Inflammatory bowel disease (IBD) is a chronic relapsing
inflammatory disorder of the gastrointestinal tract, comprising
ulcerative colitis (UC) and Crohn’s disease (CD). Defective
regulation of T cell responses to the gut flora contributes to the
aetiology of IBD and several mouse models for IBD are based on
alterations in T lymphocyte subsets [1–2]. As T lymphocytes are
shown to be one of the key cells involved in the aberrant immune
responses in IBD it is of great interest to study the generation of
new T lymphocytes in this setting.
In early age, thymus is the main organ for development of new
naı ¨ve, immunocompetent T lymphocytes that will be exported to
the periphery, seeding the peripheral lymphoid organs. Thymic
atrophy begins from the time of sexual maturity, in both humans
and mice [3], and the export of T lymphocytes from the thymus is
then decreasing with age. Even though the total egression of
thymocytes decreases with time, an export rate of 1–2% of the
total thymocytes pool remains constant throughout life [3–4].
Acute thymic atrophy is a phenomenon induced by stress,
pregnancy [5], infections or autoimmune disease [6] where the
thymus in many case is later replenished and recovered [7], while
thymic atrophy caused by age is irreversible.
The Gai2
2/2 mouse is a well-established model for colitis [8–
10] with T helper type 1 (Th1) driven inflammation with increased
levels of interferon-c (IFN- c), interleukin-1a (IL-1a), IL-6 and
tumour necrosis factor- a (TNF- a) in inflamed tissue [10]. We and
others have previously demonstrated a dramatic thymic involution
in Gai2
2/2 mice with aberrant thymocyte development compared
to control littermates [11–12]. The fraction of double positive (DP)
thymocytes was severely reduced, resulting in an increased fraction
of single positive (SP) thymocytes [11–12]. We have also found a
similar aberrant thymocyte development in dextran sulphate
sodium (DSS)-induced colitic mice [7]. In addition, IL-2 deficient
mice challenged in vivo with TNP-KLH exhibit a thymocyte
maturation defect [2]. Chemotaxis studies in Gai2
2/2 mice
demonstrated an impaired capacity of thymocytes as well as
colonic lamina propria lymphocytes to respond to CXCL12
compared to wild type mice [11]. Taken together, these
observations suggest that the aberrant thymocyte development in
mouse models of colitis might be a key event contributing to the
development of colitis. A detailed study of the thymocyte
development by Zhang et al. proposed an accelerated transition
from DP to SP in Gai2
2/2 mice [12]. Since DP thymocytes
proliferate vigorously before they develop into SP thymocytes one
would expect that the reduced number of DP thymocytes would
severely reduce the egression (export rate) of thymocytes from the
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place from the DP stage to the late SP stage as well as the
dynamics in the periphery, which enabled us to estimate the
thymic export rate in Gai2
2/2 mice. The thymic T lymphocyte
production was estimated taking advantage of an intrinsic feature
of the T cell receptor (TCR) rearrangement process that results in
the generation of unique TCR excision circles (TRECs), a
traceable molecular marker in newly produced T cells [13–14].
TRECs are stable and not duplicated during mitosis, and are thus
diluted with each cell division [15]. The levels of TRECs in the
periphery and the thymus can therefore be used to calculate the
thymic export rate [16]. The method has been extensively used to
study T cell reconstitution in highly active antiretroviral therapy
(HAART) treated HIV-patients [17], thymic export function in
relapsing remitting multiple sclerosis (RRMS) [18] and rheuma-
toid arthritis (RA) [19–20]. We have previously used estimation of
TRECs levels to study the amount of recent thymic emigrants
(RTEs) in the mucosa of IBD patients and found increased levels
of RTEs in inflamed colons of UC patients compared to un-
inflamed controls and CD patients [21]. Besides studies on thymus
function in humans, TRECs have also been used in studies on
aging mice [22], as well as studies on peripheral effects of IL-7 on
RTEs in mice [23] and in experimental graft-vs-host disease
(GVHD) [24]. Although these mouse models, including the
Gai2
2/2 mice, involve increased numbers of activated T
lymphocytes compared to the control littermates, only a small
fraction of specific T lymphocytes are activated, which proliferate
and are distributed to the site of inflammation. Hence, by studying
only TREC
+ T lymphocytes, the proliferating T lymphocyte
clones is excluded from the calculation of the thymic egression.
Hence, this method is therefore a reliable method to use for mouse
models, such as the Gai2
2/2 mice, to analyze the thymic function
and how this affects thymic egression during colitis development.
The aim of this study was to quantify a number of critical
parameters that might be affected during the onset of colitis in
order to narrow down the possible mechanisms that may cause the
aberrant thymocyte development seen in mouse models of colitis.
Materials and Methods
Ethics statement
All animals procedures were carried out under local and
national ethical guidelines (Swedish Board of Agriculture) and
were approved by the regional ethical committee, Gothenburg
Administrative Court of Appeal, with the ethical approval ID 281-
2010.
Mice
Gai2-deficient (Gai2
2/2) and healthy Gai2
+/2 control litter-
mates on a pure 129SvEv background were used. The animals
were kept at the Laboratory of Experimental Biomedicine,
Go ¨teborg University. Gai2
2/2 and Gai2
+/2 mice were bred
using heterozygote males and females and the offspring were
genotyped by polymerase chain reaction using tail genomic DNA.
Gai2
2/2 mice develop a lethal colitis between four and seven
weeks of age while Gai2
+/2 mice remain healthy. The latter is
from now on referred as wild type (wt) or control mice. Gai2
2/2
and wt mice were sacrificed between four and nine weeks of age
and Gai2
2/2 mice were scored macroscopically from 0 to 8p
based on the following criteria: a) General (clinical) condition (0–
4p); Passive/alert, presence/absence of ‘‘humpback’’ posture, ruff
fur, soft faeces or diarrhoea, b) Visible signs of inflammation in
colon (0–4p); colour (transparent or white) and thickness. They
were then grouped into no/mild colitis; (0–2p), moderate colitis;
(3–4p) or severe colitis; (5–8p). All mice were anaesthetized with
isoflouran and then sacrificed by cervical translocation. As the
kinetics of colitis development is similar in males and females, both
sexes were used. All mice were maintained in micro-isolator racks
with free access to water and rodent pellets in accordance with
local and national ethical regulations and were health-screened in
accordance with recommendations from the Federation of
European Laboratory Animal Science Associations (FELASA),
where they were confirmed to be specific pathogen free.
Cell preparation
Mice were anaesthetized with isoflouran and blood was
collected by retro-orbital puncture in tubes containing EDTA,
before sacrifice. The blood volume was recorded and the blood
was diluted 1:4 in phosphate-buffered saline (PBS), and then stored
on ice for maximum 1 h. Peripheral blood collected from Gai2
+/2
mice was pooled (3 mice/pool), as well as from two no colitis
Gai2
2/2 mice while the blood from the rest of the Gai2
2/2 mice
was analyzed individually. Peripheral blood mononuclear cells
(PBMCs) were isolated by Ficoll/Hypaque (Amersham Biosciences
AB, Uppsala, Sweden) density gradient centrifugation. The thymic
lobes were dissected and pressed through a 100 mm nylon net.
Thymocytes were then diluted in PBS and stored on ice for a
maximum of 1 h. To enrich for the mature thymocyte population
within the total thymocyte pool in wt mice, the cells were stained
with anti-CD62L-conjugated magnetic beads (130-049-701, Mil-
tenyi Biotec GmbH, Bergisch Gladbach, Germany) and separated
twice on the positive selection program on an autoMACS Pro
Separator (Miltenyi Biotec GmbH). PBMCs and thymocytes were
washed twice in PBS and diluted in 6 ml RPMI-1640 medium
containing 10% heat inactivated fetal calf serum (FCS) and then
stored on ice for a maximum of 24 h.
Flow cytometric analysis and cell sorting
Mature thymocytes were purified by flow cytometry: 2610
6
thymocytes per well in 5 wells were stained with the following
antibodies: rat-anti-mouse-CD4-Phycoerythin-TexasRed (ECD)
(GK1.5) (Abcam, Cambridge, UK), rat-anti-mouse-CD8-Phycoer-
ythin-Cyanine-5 (PE-Cy5) (53-6.7) (Southern Biotech, Birming-
ham AL, US), hamster-anti-mouse-CD69-Phycoerythin (PE)
(H1.2F3) (BD Biosciences Pharmingen, San Diego CA, US), and
rat-anti-mouse-CD62L-Fluorescein isothiocyanate (FITC) (MEL-
14) (BD Biosciences Pharmingen,), diluted in PBS 1% FCS up to a
total volume of 30 ml and then incubated at 4uC for 20 min. For
flow cytometric sorting of T lymphocytes in peripheral blood, 1–
2610
6 PBMCs in a volume of 30 ml were stained with hamster-
anti-mouse-CD3-PE (145-C211) (BD Biosciences Pharmingen).
For analysis of naı ¨ve T lymphocytes, about 1610
5 PBMCs were
stained with hamster-anti-mouse-CD3-PE (145-C211) and rat-
anti-mouse-CD62L-FITC (MEL-14) (both from BD Biosciences
Pharmingen). Analysis of the frequency of apoptotic naı ¨ve CD4
+ T
cells in peripheral blood was performed as follows; 1610
5 PBMCs
were diluted in 100 ml Binding buffer (BD Biosciences Pharmin-
gen) and then stained with rat-anti-mouse-CD4-ECD (Abcam),
rat-anti-mouse-CD8-PE-Cy5 (Southern Biotech), AnnexinV-FITC
and Propidium Iodide (both from BD Biosciences Pharmingen),
incubated for 15 min at r.t. and then analysed within one hour. All
flow cytometric analyses and cell sorting was performed on an
EPICSH ALTRA
TM, (Beckman Coulter, Fullerton, CA, US).
Mature thymocytes were gated and sorted as CD4
+
CD62L
+(CD8
2CD69
2/low) and CD8
+CD62L
+(CD4
2CD69
2/low)
cells, respectively and peripheral blood mononuclear cells were
gated and sorted based on the expression of CD3. The purity of
mature thymocytes was 90–98% and CD3
+ PBMCs were 80–95%
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Coulter).
DNA extraction and real time-PCR for analysis of TRECs
content
1–5610
5 sorted CD4
+CD62L
+ and CD8
+CD62L
+ thymocytes
and CD3
+ peripheral blood T lymphocytes were centrifuged, the
supernatants were discarded. The pellets were diluted in 100 ml
PBS, 100 ml Lysis buffer AL and 10 ml Proteinase K, and
incubated at 56uC for 10 min according to the manufacturer’s
instructions (Qiagen, Hilden, Germany). The cell lysates were then
stored at r.t. 1–2 weeks until DNA extraction. DNA was isolated
and purified using the QIAmp DNA blood micro kit, according to
the manufacturer’s instructions (Qiagen). Prior to the real time-
polymerase chain reactions (real time-PCR), DNA concentrations
in all samples were determined using a NanoDropH Spectropho-
tometer ND-1000 (NanoDrop Technologies, Wilmington, DE,
US) at 260 and 280 nm wave lengths. The percentage of signal
joint (sj) TRECs
+ cells was identified by quantitative real time-
PCR using a 7500 Real time-PCR System (Applied Biosystems,
Warrington, UK). The DNA content from male and female
laboratory mice cell nuclei have an estimated weight of 5.93 and
6.14 pg/nucleus, respectively (mean value calculated from 5
different strains; Balb/c, C57BL/6, CD1, C3H/heJ, and DBA
and 10 different F1 hybrids crossed from these strains) [25].
Separate standard curves were set up, based on the DNA weight
for male and female mice separately, starting with 59.3 ng and
61.4 ng, respectively, representing DNA from 1610
4 cells and
were then diluted 10 times in each step for an additional 3 steps.
To identify the number of cells in each sample in the standard
curve, primer/probe was targeted for a unique DNA sequence
within the glucagon gene, previously used as reference sequence
[26–27]. The standard curve was run in parallel to the sample on
the same plate and was used to calculate the percentage of
sjTRECs in each sample based on the total amount of cells. Each
20 ml PCR reaction contained 10 ml FastMasterMix (Applied
Biosystems), 2 ml of each primer (1.1 mM), 2 ml probe (0.25 mM)
and 4 ml of sample DNA (1–20 ng/ml). The PCR was performed
as follows: Initial step at 50uC for 2 min followed by 10 min initial
denaturation at 95uC and subsequently 40 cycles of denaturation
at 95uC for 15 sec followed by annealing/extension at 60uC for
1 min.
The following sequences of primers and probes were used:
Glucagon sequence; forward primer 59-CACAA-
CATCTCGTGCCAGTCA-39, reverse primer 59-ATCTG-
CATGC AAAGCAATATAGCT-39 and TaqMan MGB probe
FAM-59-GGGATGTACAATTTCAA-39-TAMRA. SjTRECs se-
quence: forward primer 59-CAGGGCAGGTTTTTG-
TAAAGGT-39, reverse primer 59-CCTGAGCATGGCAAG-
CAGTA-39 and TaqMan probe FAM-59-
TGCTGTGTGCCCTACCCTGCCC-39-TAMRA. All primers
and probes were purchased from Invitrogen Life Technologies,
Paisley, UK and Applied Biosystems, respectively.
Calculations of the thymic export rate
By using the proposed kinetic model of peripheral TREC
+ T
cells by Hazenberg et al. [17]:
dT
dt
~as{dT
one can calculate the daily thymic export rate. The model is
described as a differential equation, where dT/dt is the rate of
change of TREC
+ T cells in the periphery, a is the proportion of
TREC
+ cells exiting the thymus, s is the export rate and d is the
loss rate of TREC
+ T cells. By assuming that the peripheral
TREC
+ T cells are at steady state (dT/dt=0), the equation can be
solved for the thymic export rate:
s~
a  T T
d
:
In this study we determined the fraction of TREC
+ thymocytes
within the most mature thymocyte populations (CD4
+CD62L
+
and CD8
+CD62L
+). This fraction corresponds to the parameter a
in the model [16]. We also estimated the number of TREC
+ T
cells in the periphery, corresponding to the parameter   T T,b y
counting the total number of TREC
+ T cells in the blood and
multiplying this number with 50, since 1/50 of all peripheral
lymphocytes are located in the blood [16,28–29]. The loss rate (d)
of TREC
+ T cells was taken from other studies, where a death rate
of the majority of naı ¨ve T cells has been found to be 0,05/day in
mice [28,30].
Results
Unchanged amounts of single positive thymocytes in
Gai2
2/2 mice during early colitis despite a dramatic
reduction of double positive thymocytes
Gai2-deficient (Gai2
2/2) mice develop a severe thymic atrophy
before any clinical symptoms of colitis are evident. To follow the
progress of thymic atrophy, we first analysed the three main
thymocyte populations; DP (CD4
+CD8
+), CD4 SP and CD8 SP
thymocytes in wt mice based on their age (4–9 weeks). No
significant changes in the numbers or fractions of DP or SP
thymocytes were observed within the control (Gai2
+/2) littermate
group based on their age: Age 4–5 w: 95.6655.2610
6 DP,
18.3611.6610
6 CD4 SP and 10.267.2610
6 CD8 SP; age 6–7 w:
107.8610.5610
6 DP, 24.766.1610
6 CD4 SP and 13.765.1610
6
CD8 SP; 8–9 w: 72.466.1610
6 DP, 15.562.5610
6 CD4 SP and
7.562.9610
6 CD8 SP. The data were therefore collected into a
single control group. We next analyzed the size of the major
thymocyte population of the Gai2
2/2 mice compared to the
control group. The Gai2
2/2 mice were first grouped according to
their macroscopic colitis scores and the fraction and number of the
different thymocyte populations (DP, CD4 SP and CD8 SP) was
analyzed (Fig. 1). The mean frequency of DP thymocytes in
Gai2
2/2 mice with no/mild colitis was significantly lower than in
wt mice (Fig. 1A). As the colitis progressed, the frequency of DP
thymocytes continued to decrease. The accelerated reduction of
the DP thymocyte fraction in the Gai2
2/2 mice was also reflected
in the total number of DP thymocytes. Gai2
2/2 mice with no/
mild colitis had a mean value of ,37610
6 DP thymocytes, which
was significantly reduced compared to the ,90610
6 DP
thymocytes observed in the wt mice, and this reduction was even
more pronounced in the more advanced stages of colitis (Fig. 1B).
The frequency of CD4 and CD8 SP thymocytes increased
gradually and significantly with the progression of colitis in
Gai2
2/2 mice, compared to ,16% of CD4 SP and ,8% of CD8
SP thymocytes in the control mice (Fig. 1C & 1E). However, the
total numbers of CD4 or CD8 SP thymocytes in Gai2
2/2 mice
with no/mild and moderate colitis were comparable to the
numbers in wt littermates (Fig. 1D & F). Hence, although the
number of DP thymocytes decreased with progression of colitis,
the numbers of SP thymocytes were comparable to the control
littermates. However, mice with severe colitis showed significantly
reduced numbers of both CD4 and CD8 SP thymocytes compared
Thymic Atrophy in G-alpha-i2 Colitis
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36726to the littermate controls. Next, we repeated this analysis with the
Gai2
2/2 mice grouped according to age (4–8 weeks) instead of
macroscopic scoring. A correlation analysis showed a stronger
correlation between macroscopic colitis scores and the fraction (or
number) of DP thymocytes of the total thymocytes compared to
the correlation between age groups of Gai2
2/2 mice and the
fraction (or number) of DP of the thymocytes (Table 1).
Comparable frequencies of TRECs
+ mature thymocytes in
wt and Gai2
2/2 mice indicate equivalent numbers of
divisions during transition from DP to mature SP
thymocytes
As a part of the T lymphocyte maturation process in thymus,
early DP thymocytes undergo an extensive rearrangement of the T
cell receptor (TCR) genes, leaving circles of untranscribable DNA
in the nucleus, one of which is termed signal joint T cell receptor
excision circle (sjTREC). The sjTRECs are formed during the a-
chain rearrangement at the developmental stage of DP thymocytes
and remain stable within the cells. They are then diluted as the
thymocytes undergo proliferation and develop into mature SP
thymocytes. Knowing that Gai2
2/2 mice have an abnormal
thymocyte composition compared to wt mice, we analysed
whether the frequency of sjTREC
+ mature thymocytes differed
in Gai2
2/2 mice during development of colitis compared to wt
littermates. Mature thymocytes were sorted based on the following
phenotype: CD4
+CD8
2CD62L
+CD69
2/low as well as
CD8
+CD4
2CD62L
+CD69
2/low (from now on referred to as
CD4
+CD62L
+ and CD8
+CD62L
+ thymocytes, respectively) and
analysed for the content of sjTRECs by quantitative real time-
PCR. We first compared the frequencies of CD4
+CD62L
+ and
CD8
+CD62L
+ thymocytes containing sjTRECs in 4 to 9 weeks old
healthy wt mice; no significant differences in the frequencies of
sjTRECs were found between the different age groups (age 4–5 w:
13.365.3% CD4
+CD62L
+ and 10.162.3% CD8
+CD62L
+; age
6–7 w: 18.964.7% CD4
+CD62L
+ and 15.463.8% CD8
+CD62L
+
and age 8–9 w: 18.366.7% CD4
+CD62L
+ and 20.669.8%
CD8
+CD62L
+). We therefore pooled the data from the wt mice
into a single control group. The wt mature CD4 SP and CD8 SP
populations had comparable fractions of sjTREC
+ thymocytes,
indicating that in the wt mice the thymocytes undergo the same
number of divisions from the a-chain rearrangement stage until
they are mature SP thymocytes (Fig. 2). The sjTREC
+ fractions of
mature Gai2
2/2 thymocytes were similar in both the
CD4
+CD62L
+ and CD8
+CD62L
+ populations, and did not
significantly change during colitis development (Fig. 2). In
addition, the fractions of sjTREC
+ mature thymocytes were not
significantly different between the control littermates and
Gai2
2/2 mice. These results strongly indicate that the numbers
of divisions the thymocytes undergo during the transition from DP
to mature SP thymocytes are not different between Gai2
2/2 and
Gai2
+/2 mice.
Reduced numbers of TREC
+ T lymphocytes in peripheral
blood in mice with no/mild and moderate colitis
Next, we evaluated if the observed dynamical changes of the
Gai2
2/2 thymocytes maturation affect the number of T
lymphocytes in peripheral blood. The number of naı ¨ve T
lymphocytes and total amount of T lymphocytes in peripheral
blood were calculated based on the fraction of CD3
+CD62L
+ cells
or CD3
+ cells (data not shown) of the total PBMCs population.
Since the number of T lymphocytes as well as the number of
TREC
+ T lymphocytes in peripheral blood were stable with
increasing age in 4–9 week old wt mice (no. of T lymphocytes and
TREC
+ T lymphocytes at age 4–5 w: 1.460.8610
6 and
1.660.9610
5; age 6–7 w: 2.360.6610
6 and 2.361.3610
5; and
age 8–9 w: 1.961.1610
6 and 2.461.8610
5, respectively), the
different age groups where grouped into a single wt control group.
The control mice had a mean value of ,1.8610
6 T lymphocytes
and ,1.5610
6 naı ¨ve T lymphocytes in peripheral blood (Fig. 3A
and B). The amount of naı ¨ve T lymphocytes and total amount of
T lymphocytes in Gai2
2/2 mice were comparable to the control
mice, with one exception: The numbers of T lymphocytes were
significantly lower in Gai2
2/2 mice with no/mild colitis
compared to those with severe colitis (Fig. 3A). The mean fraction
of TREC
+ cells among the total T lymphocytes in peripheral
blood of wt mice were found to be 10% (Fig. 3C), i.e. about half
the fraction of TREC
+ cells found in the wt mature thymocyte
population (Fig. 2). This indicates that the peripheral blood T
lymphocytes in wt mice have undergone on average one division
since their most mature stage in thymus. Analysis of the Gai2
2/2
mice showed that only mice with moderate colitis had a
significantly lower fraction of TREC
+ peripheral T lymphocytes
compared to control littermates (Fig. 3C).
We next calculated the total number of TREC
+ T lymphocytes
in peripheral blood by multiplying the total number of peripheral
T lymphocytes with the fraction of TREC
+ lymphocytes in the
corresponding mice (Fig. 3D). This is an important parameter for
estimating the daily egression of T lymphocytes since the number
of TREC
+ T lymphocytes in peripheral blood is independent on
the T lymphocyte proliferation. The Gai2
2/2 mice with no/mild
and moderate colitis had significantly lower numbers of TREC
+
peripheral blood T lymphocytes compared to their control
littermates (Fig. 3D).
Reduced egression of thymocytes in Gai2
2/2 mice with
no/mild and moderate colitis
So far we had found only small differences in the total numbers
of mature CD4 and CD8 SP thymocytes between Gai2
2/2 mice
and control littermates (Fig. 1) as well as the fraction of TREC
+
mature thymocytes (Fig. 2). However, a significant reduction in the
number of TREC
+ T lymphocytes in peripheral blood was
demonstrated in Gai2
2/2 mice with no/mild and moderate colitis
(Fig. 3D). To examine whether this resulted in a change in the
daily egression of thymocytes to peripheral blood during
progression of colitis, we next analysed the thymic egression rate
of mature thymocytes. We first examined the fraction of apoptotic
peripheral T lymphocytes in Gai2
2/2 mice and control
littermates. Naı ¨ve peripheral blood CD4
+ T lymphocytes from
Gai2
2/2 and wt mice were stained with Annexin V and PI and
analysed by flow cytometry. No significant difference in the
fraction of cells staining positive for these apoptotic markers were
found between mice with different macroscopic scoring, and
therefore these mice were collected into a single group. The results
showed comparable frequencies of apoptotic naive CD4
+ T
lymphocytes in wt and Gai2
2/2 mice (Fig. 4A). Next, we
estimated the daily egression of thymocytes to peripheral blood.
The calculations were based on the fraction of mature TREC
+
thymocytes (Fig. 2), a death rate of 0.05/day of peripheral T
lymphocytes as previously observed [28,30], and the number of
TREC
+ T lymphocytes in the periphery (Fig. 3D) multiplied with
50 to account for that 1/50 of all the lymphocytes reside in the
blood [28–29]. Since peripheral T lymphocytes of Gai2
2/2 and
wt mice showed comparable fractions of cells that were positive for
apoptotic markers, we assume equal death rates of Gai2
2/2 and
wt mice. The calculations show that control mice at ages 4–9
weeks had an average thymic egression of 3.4–4.0610
6 thymo-
cytes per day (age 4–5 w: 3.462.1610
6, age 6–7 w: 3.963.1610
6
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36726Figure 1. Decreased numbers and frequencies of DP thymocytes but equal numbers of SP thymocytes in Gai2
2/2 mice compared to
control mice. Flow cytometric analyses of the frequencies and total numbers of CD4
+8
+ (DP) (A–B), CD4
+8
2 (CD4 SP) (C–D) and CD4
28
+ (CD8 SP) (E–
F) thymocytes. Results from wt mice (n=28–31) and Gai2
2/2 mice (n=6–14) are shown as frequencies or numbers of thymocytes from individual
mice with the mean within each group presented as a horizontal line. The control group consisted of 4–9 weeks old wt mice whereas the Gai2
2/2
mice were 4–8 weeks old, grouped based on their colitis score; no and mild colitis (rectangles and triangles, respectively), moderate (dark gray circles)
and severe colitis (black circles). Statistical analysis was performed using the Mann-Whitney non-parametric test and values of p#0.05 were
considered significant, *p#0.05; **p#0.01 and ***p#0.001 between Gai2
2/2 mice and control mice or between Gai2
2/2 mice with different colitis
scores.
doi:10.1371/journal.pone.0036726.g001
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6), with a mean value of 4.0610
6
thymocytes/day (Fig. 4B). The Gai2
2/2 mice with no/mild and
moderate colitis had a significantly reduced thymic egression rates,
0.87610
6 and 1.8610
6, respectively, compared to wt mice.
However, mice with severe colitis showed thymic egression rates
comparable to the control littermates.
Discussion
Acute thymic atrophy has been reported in various situations;
during infectious disease [31], pregnancy [5] autoimmune disease
[6] and stress [32]. This identifies the thymus as a common target
of several pathological and physiological situations. We have
previously reported thymic atrophy in Gai2 deficient mice and the
resulting reduced frequencies and numbers of cortical thymocytes
as well as reduced responsiveness to chemokines involved in
thymocyte migration [11]. In this study, we show that the
decreased numbers of DP thymocytes correlate well with the
progression of colitis in the Gai2-deficient mice. Zhang et al. have
previously observed a dramatic reduction of the DP thymocytes
with increasing age in Gai2-deficient mice on a C57BL/6
background, which do not develop severe colitis [12]. Hence, this
suggests that both the severity of colitis and the age of the Gai2-
deficient mice are likely to affect the number of DP thymocytes.
Interestingly, although the fraction of SP thymocytes increased
during the progression of colitis their actual numbers remained
largely unchanged. Thus, the increased fraction of SP thymocytes
is a result of the reduced numbers of DP thymocytes and does not
generally depend on changes in the actual numbers of SP
thymocytes. Since the numbers of DP thymocytes, the main source
for the SP population, were reduced, one would expect a reduction
of the SP population as well. A number of factors may be involved
to cause this aberrant thymocyte dynamics in the Gai2-deficient
mice. The DP thymocytes might die more frequently and to
restore the SP thymocyte population the Gai2
2/2 SP thymocytes
would need to proliferate more extensively and thus result in more
diluted sjTRECs. However, we were unable to detect any
differences in the frequencies of TREC
+ mature thymocytes
between the Gai2
2/2 mice and the control littermates. This is
supported by previous cell cycle analyses of SP thymocytes
demonstrating comparable fractions of cells being in the S+G2-M
phase between Gai2
2/2 and wt SP thymocytes [12]. Hence, an
increased proliferation of Gai2
2/2 SP thymocytes is not a
compensatory mechanism to restore the number of SP thymocytes
in the setting of reduced numbers of DP thymocytes. Another
possibility is that Gai2
2/2 SP thymocytes do not die as frequently
as the wt SP thymocytes. However, mature SP thymocytes have
been shown to be largely resistant to cell death [33]. In addition,
Jin and Wu reported that the lack of the Gai2 protein resulted in
reduced homing of blood-borne progenitor cells and caused arrest
of thymocyte differentiation at the DN1 stage [34]. The
observation that the death rate and the proliferation rate of
Gai2
2/2 DP thymocytes were comparable to wt mice [8,12]
suggests that the most likely mechanisms generating decreased
numbers of DP but comparable numbers of SP thymocytes in
Gai2
2/2 compared to control littermates are: (i) an accelerated
transition rate from DP to SP thymocytes, (ii) a reduced
Table 1. Spearman’s correlation analysis between age or
colitis score and fraction or number of the different
thymocyte subpopulations.
Age
a Colitis score
b
Variable rs pr s p
%D P 20.63 1.9N10
24 20.85 2.7N10
29
% CD4 0.68 3.2N10
25 0.82 4.0N10
28
% CD8 0.58 8.7N10
24 0.77 4.8N10
27
# DP 20.54 1.9N10
23 20.72 5.9N10
26
# CD4 20.17 0.37 20.11 0.57
# CD8 20.23 0.21 20.23 0.31
aThe different age groups were: 4 (n=9), 5 (n=7), 6 (n=5), 7 (n=6) and 8 weeks
(n=3).
bThe different colitis score were: 0p (n=3), 0.5–2p (n=3), 2.5–4p (n=14), 4.5–6p
(n=6) and 6.5–8p (n=4).
doi:10.1371/journal.pone.0036726.t001
Figure 2. The frequencies of TRECs in mature thymocytes in Gai2
2/2 mice are independent of the colitis score. Mature
CD4
+CD8
2CD62L
+CD69
2 and CD8
+CD4
2CD62L
+CD69
2 thymocytes from wt mice and Gai2
2/2 mice were sorted by flow cytometry. DNA from the
sorted thymocytes were analysed for the amount of TRECs specific DNA by real time-PCR. The frequencies of TRECs
+ cells in CD4
+CD62L
+ (white
symbols) and CD8
+CD62L
+ (gray symbols) thymocytes were analysed in 4–9 weeks old wt mice (n=28) and 4–8 weeks old Gai2
2/2 mice (n=5–13),
grouped based on colitis scores (rectangles=no colitis, triangles=mild colitis). The mean frequencies within each group are represented as a
horizontal line. Statistical analysis was performed using the Mann-Whitney non-parametric test and values of p#0.05 were considered significant.
doi:10.1371/journal.pone.0036726.g002
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reside longer in the thymus, i.e. egress more slowly, thus enabling
accumulation of SP thymocytes. In support of this, Zhang et al.
has previously proposed that Gai2
2/2 mice have an accelerated
transition from DP to SP thymocytes [12], and our data indeed
support this theory. In addition, in our previous work we
demonstrated an accumulation of the most mature thymocytes
in pre-colitic Gai2
2/2 mice before egress from the thymus,
supporting the latter explanation [11]. The lack of the Gai2
protein may also affect the chemotactic response within the
thymus. We have previously reported that the numbers of cortical
DP as well as early medullary SP thymocytes migrating towards
the medulla in response to CXCL12 were decreased [11]. In
addition, this decreased migratory response could not be explained
by decreased expression of CXCR4 [11]. The spontaneous
mobility, i.e. without chemokines was, however, increased in
pre-colitic mice, supporting the hypothesis of an accelerated
transition rate from DP to SP thymocytes [11]. In addition, our
calculations of the thymic egression rate also showed that Gai2
2/2
mice with no/mild and moderate colitis have a reduced egression
Figure 3. Decreased frequencies and numbers of TRECs in peripheral blood CD3
+ T lymphocytes in colitic Gai2
2/2 mice. Peripheral
blood was collected and the volume recorded from individual mice, whereafter Gai2
+/2 mice were pooled (3 mice/pool) and analysed, while
peripheral blood from Gai2
2/2 mice was analysed individually. The control group of wt mice were 4–9 weeks old (n=11–16, white circles) and the
Gai2
2/2 mice were 4–8 weeks old (n=4–14, gray/black symbols), grouped based on their colitis scores (no colitis=rectangles, mild colitis=triangles).
PBMCs were isolated from peripheral blood and the frequencies of CD3
+ T lymphocytes was analysed by flow cytometry. The number of CD3
+ (A) and
naı ¨ve T lymphocytes (B) are presented as total T lymphocytes of the entire blood volume in each mouse, 6–8 ml blood per 100 g body weight [40].
(C) The frequencies of TREC
+ lymphocytes were analysed by real time-PCR on isolated DNA from flow cytometry sorted peripheral blood CD3
+ T
lymphocytes. (D) Numbers of TREC
+ CD3
+ peripheral blood lymphocytes, as calculated from data (A) and (C). Horizontal lines indicate the mean
within the group. Statistical analysis was performed using the Mann-Whitney non-parametric test and values of p#0.05 were considered significant.
*p#0.05; **p#0.01 and ***p#0.001 between Gai2
2/2 and wt mice.
doi:10.1371/journal.pone.0036726.g003
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moderate colitis is due to the low number of TREC
+ T
lymphocytes observed in peripheral blood since neither of the
other parameters showed a significant difference. Even though the
method we use to calculate the export rate is a rough estimation,
we obtained similar egression rates as the ones previously reported
in mice, [30,33,35–37] ranging from 1–5 million per day. Our
calculations of the daily thymocyte egression rate in 4–9 week old
wt mice were ,4 million or ,3% of the total numbers of
thymocytes. A reduced export rate during aging was not observed
in the wt mice in this study, which is consistent with the report by
Sempowski et al., who only observed a declined TREC
+ fraction
of mouse peripheral T lymphocytes after the age of 35 weeks [22].
In addition, the frequency of sjTREC containing mature
thymocytes has previously been reported to be around 10–15%
in healthy individuals [38–39], which is similar to what we
obtained. The mature CD4 or CD8 SP thymocytes in the wt mice
had an equal percentage of TREC
+ cells. This suggests that CD4
and CD8 SP thymocytes undergo the same number of divisions
before they enter the periphery, which is supported by kinetic
studies of thymocyte development [33]. The method we used to
calculate the export rate is one of the most commonly used
methods used to predict the export rate [16] and the values for the
individual parameters also seem to be in line with what others
have reported. The only parameter that we did not measure
directly was the death rate of TREC
+ T lymphocytes. Since the
mice are kept in a pathogen free environment and that a
considerable fraction of T lymphocytes are not specific for antigens
involved in colitis, most of the TREC
+ T lymphocytes will remain
in their naı ¨ve state. In addition, the frequency of peripheral naı ¨ve
T lymphocytes undergoing apoptosis were comparable between
Gai2
2/2 and wt control mice, further supporting our assumption
of equal death rates of TREC
+ T lymphocytes in Gai2
2/2 and wt
mice.
The finding that mice with severe colitis have thymic egression
rates comparable to their control littermates was unexpected.
However, these mice have reached a critical disease stage where
the homeostatic balance might be completely lost. Since these
mice will have leakage of plasma fluids into peripheral tissues, the
appreciated blood volume of them might be over estimated. A
reduced blood volume in our calculations will reduce the amount
of TREC
+ T lymphocytes and consequently the egression rate. In
addition, there is an uncertainty in the data since two distinct mice
show about five-fold higher egression rate compared to the other
mice in this group. Hence, further investigations are needed to
confirm the thymic egression rates in mice with severe colitis.
In conclusion, we propose a possible chain of events that occurs
during the progress of colitis in the Gai2
2/2 mice. The reduced
number of DP thymocytes is due to an accelerated transition from
DP to SP thymocytes and/or a reduced transition from DN to DP
thymocytes. In order to keep the SP cells at a normal level even
though the number of DP thymocytes is reduced, the SP
thymocytes reside longer within the thymus before they egress.
Thus, this results in a lower daily production by the thymus.
Future studies revealing the exact mechanisms behind the altered
transition rates in colitic mice will provide important information
about the thymic atrophy during colitis.
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